Filing Details

Accession Number:
0000914190-16-000841
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-10-05 17:36:20
Reporting Period:
2016-10-03
Filing Date:
2016-10-05
Accepted Time:
2016-10-05 17:36:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1195116 Arno Therapeutics Inc ARNI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1170542 M David Tanen 200 Route 31 North
Suite 104
Flemington NJ 08822
Secretary Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-10-03 142,857 $0.00 314,569 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock 2016 Series F Warrants (right to buy) Acquisiton 2016-10-03 71,428 $0.00 71,428 $0.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
71,428 2016-10-03 2021-10-03 No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 362,015 Indirect By Trust
Common Stock 18,691 Indirect By spouse for minor children
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $8.00 2019-09-29 1,250 1,250 Direct
Common Stock Stock Option (right to buy) $8.00 2020-11-05 1,250 1,250 Direct
Common Stock Stock Option (right to buy) $2.40 2023-11-04 68,448 68,448 Direct
Common Stock Stock Option (right to buy) $2.90 2024-01-24 34,224 34,224 Direct
Common Stock Stock Option (right to buy) $0.37 2026-04-07 88,628 88,628 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2019-09-29 1,250 1,250 Direct
2020-11-05 1,250 1,250 Direct
2023-11-04 68,448 68,448 Direct
2024-01-24 34,224 34,224 Direct
2026-04-07 88,628 88,628 Direct
Footnotes
  1. Held by the David M. Tanen Revocable Grantor Trust, of which the Reporting Person is a beneficiary.
  2. Held by the Reporting Person's spouse as custodian for the benefit of their minor children under the Uniform Gift to Minors Act. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or any other purpose.
  3. The reported securities are included within 142,857 units of the Issuer's securities that the Reporting Person committed to purchase, at a per unit price of $0.35, pursuant to the Securities Purchase Agreement dated 8/15/16, a copy of which was filed as Exhibit 10.1 to the Issuer's Form 8-K filed 8/16/16.
  4. Currently exercisable.
  5. Vests in equal 36-monthly installments commencing 12/4/13.
  6. Vests in equal 12-monthly installments commencing 5/7/16.